Patient Zero
| Name | Patient Zero |
|---|---|
| Type | Creature — zombie |
| Description | Lifelink Damage isn't removed from creatures your opponents control during cleanup steps. |
| Artist | Peter Polach |
| Set | Alchemy: Innistrad #999-PZ |
| Wallpaper |  download |
| Image |  download |
Tierlist
No Rank
Grade it yourself
Table of contents
About Patient Zero
Patient Zero, Creature — zombie, designed by Peter Polach first released in Dec, 2021 in the set Alchemy: Innistrad.
This card, Patient Zero, would be beneficial in a black-based aggro deck that focuses on draining the opponent's life total while maintaining board presence. Its ability to prevent damage from being removed from creatures your opponents control can be a powerful tool to maintain pressure on the opponent. However, there are better options available such as Vampire Nighthawk which also has lifelink but with additional abilities like flying and deathtouch, making it a more versatile and impactful choice in most scenarios. Patient Zero could see play in niche strategies that specifically benefit from its unique effect, but overall, there are stronger cards to consider for more competitive decks.
Where to buy
 | Ebay.com | Visit store | ||
 | Printing proxies | $ 0.75 | Visit store |
*This site contains affiliate links for which we may be compensated
Group by
Price alert ?
Alert me when price gets to
Price trend history
Sign in and join the conversationFrequently asked questions about Patient Zero
What type of card is Patient Zero?
Patient Zero is a Creature — zombie card in Magic: the Gathering MTG.
What does Patient Zero do?
Lifelink Damage isn't removed from creatures your opponents control during cleanup steps.
What set is Patient Zero from?
Patient Zero was first released in the set Alchemy: Innistrad, illustrated by Peter Polach.
Is Patient Zero legal to play?
Legality depends on the tournament format -- Patient Zero can be legal in some formats and banned or restricted in others. See the full breakdown per format in the Legality section above.
— Comments 0
, Reactions 1
Be the first to comment